This study evaluates the factors that contribute to chronic graft-versus-host disease, which is a complication that can occur after allogeneic hematopoietic cell transplantation.
Documented written informed consent of the participant and/or parent/guardian.
Assent from pediatric participants will be documented per institutional policies and practice.
Patients who have received allogeneic hematopoietic cell transplant (HCT) regardless of donor type, condition regimen, or GVHD prophylaxis.
Age: ≥ 18 years or ≥ 7 years if 30 kg and above
* Women of childbearing potential: Pregnant/nursing
Individuals with impaired decision-making capacity
An employee who is under the direct/ indirect supervision of the PI/ a co-investigator/ the study manager
A direct study team member
City of Hope Medical Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator